Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 are associated with systemic lupus erythematosus
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
TREX1 acts in concert with the SET complex in granzyme A-mediated apoptosis, and mutations in TREX1 cause Aicardi-Goutières syndrome and familial chilblain lupus. Here, we report monoallelic frameshift or missense mutations and one 3' UTR variant of TREX1 present in 9/417 individuals with systemic lupus erythematosus but absent in 1,712 controls (P = 4.1 x 10(-7)). We demonstrate that two mutant TREX1 alleles alter subcellular targeting. Our findings implicate TREX1 in the pathogenesis of SLE.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TREX1 mutations have been identified in SLE115 and familial chilblain lupus116, implicating TREX1 as a safeguard against autoimmune inflammation.”
From The role of retrotransposable elements in ageing and age-associated diseases (2021) · cites this paper as [115]
Citations
Cites
Recognition of Cytosolic DNA Activates an IRF3-Dependent Innate Immune Response
Stetson, D. B., & Medzhitov, R. (2006) · Immunity · doi:10.1016/j.immuni.2005.12.003 · Cited by 1,008
Crow, Y. J., Hayward, B. E., Parmar, R., Robins, P., Leitch, A., Ali, M., Black, D. N., van Bokhoven, H., Brunner, H. G., Hamel, B. C., et al. (2006) · Nature Genetics · doi:10.1038/ng1845 · Cited by 903
Features of systemic lupus erythematosus in Dnase1-deficient mice
Napirei, M., Karsunky, H., Zevnik, B., Stephan, H., Mannherz, H. G., & Möröy, T. (2000) · Nature Genetics · doi:10.1038/76032 · Cited by 789
Mutation of DNASE1 in people with systemic lupus erythematosus
Yasutomo, K., Horiuchi, T., Kagami, S., Tsukamoto, H., Hashimura, C., Urushihara, M., & Kuroda, Y. (2001) · Nature Genetics · doi:10.1038/91070 · Cited by 596
Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages
Kawane, K., Ohtani, M., Miwa, K., Kizawa, T., Kanbara, Y., Yoshioka, Y., Yoshikawa, H., & Nagata, S. (2006) · Nature · doi:10.1038/nature05245 · Cited by 470
Rice, G., Newman, W. G., Dean, J., Patrick, T., Parmar, R., Flintoff, K., Robins, P., Harvey, S., Hollis, T., O’Hara, A., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/513443 · Cited by 410
Self-citationMorita, M., Stamp, G., Robins, P., Dulic, A., Rosewell, I., Hrivnak, G., Daly, G., Lindahl, T., & Barnes, D. E. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.15.6719-6727.2004 · Cited by 380
Mendell, J. T., & Dietz, H. C. (2001) · Cell · doi:10.1016/s0092-8674(01)00583-9 · Cited by 289
Role and fate of PML nuclear bodies in response to interferon and viral infections
Regad, T., & Chelbi-Alix, M. K. (2001) · Oncogene · doi:10.1038/sj.onc.1204854 · Cited by 281
Mazur, D. J., & Perrino, F. W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.28.19655 · Cited by 276
Self-citation
Cited by
Items 201–300 of 728
Lo, M. S. (2016) · Current Rheumatology Reports · doi:10.1007/s11926-016-0621-9 · Cited by 76
Vaughn, S. E., Kottyan, L. C., Munroe, M. E., & Harley, J. B. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0212095 · Cited by 72
Günther, C., Berndt, N., Wolf, C., & Lee‐Kirsch, M. A. (2014) · JAMA Dermatology · doi:10.1001/jamadermatol.2014.3438 · Cited by 75
Self-citationGenetic predisposition to autoimmunity – What have we learned?
Rai, E., & Wakeland, E. K. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.01.015 · Cited by 84
Familial Aggregation of Autoimmune Disease in Juvenile Dermatomyositis
Niewold, T. B., Wu, S., Smith, M. K., Morgan, G. A., & Pachman, L. M. (2011) · PEDIATRICS · doi:10.1542/peds.2010-3022 · Cited by 72
RBP–RNA interactions in the control of autoimmunity and autoinflammation
Liu, J., & Cao, X. (2023) · Cell Research · doi:10.1038/s41422-022-00752-5 · Cited by 83
“RBPs can also be recognized as autoantigens, and anti-RBP antibodies are frequently detected in patients of AIDs such as SLE.235 For example, anti-Sm antibodies that interact with U1, U2, U4 and U5 RNA snRNPs are predictive for SLE classification; anti-SS-A (Ro52/Ro60) autoantibodies are described as serological marke…”
BackgroundInfluentialGenetics and Epigenetics of Systemic Lupus Erythematosus
Costa‐Reis, P., & Sullivan, K. E. (2013) · Current Rheumatology Reports · doi:10.1007/s11926-013-0369-4 · Cited by 82
“Certain TREX1 variants were found to be related to SLE suceptibility [21] and, in a large case–control study, a TREX1 haplotype was found to be associated with the risk of neurological manifestations in European SLE patients [22].”
BackgroundGenetics and novel aspects of therapies in systemic lupus erythematosus
Relle, M., Weinmann‐Menke, J., Scorletti, E., Cavagna, L., & Schwarting, A. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2015.07.003 · Cited by 79
“has been speculated that these mutations impair its function as a cytosolic DNA sensor [119].”
BackgroundKoumakis, E., Giraud, M., Dieudé, P., Cohignac, V., Cuomo, G., Airò, P., HACHULLA, E., Matucci‐Cerinic, M., Diot, E., Caramaschi, P., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34490 · Cited by 75
Endogenous retroviral pathogenesis in lupus
Perl, A., Fernandez, D., Telarico, T., & Phillips, P. E. (2010) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32833c6297 · Cited by 75
Fueling autoimmunity: type I interferon in autoimmune diseases
Domizio, J. D., & Cao, W. (2013) · Expert Review of Clinical Immunology · doi:10.1586/eci.12.106 · Cited by 71
Rethinking mechanisms of autoimmune pathogenesis
Pillai, S. S. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.05.003 · Cited by 73
Kariuki, S. N., Ghodke-Puranik, Y., Dorschner, J. M., Chrabot, B., Kelly, J., Tsao, B., Kimberly, R., Alarcón-Riquelme, M., Jacob, C., Criswell, L., et al. (2014) · Genes and Immunity · doi:10.1038/gene.2014.57 · Cited by 68
Intracellular Nucleic Acid Sensors and Autoimmunity
Theofilopoulos, A. N., Kono, D. H., Beutler, B., & Baccalà, R. (2011) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2011.0092 · Cited by 73
Leffers, H. C. B., Lange, T., Collins, C. E., Ulff-Møller, C. J., & Jacobsen, S. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.11.005 · Cited by 75
Chance, genetics, and the heterogeneity of disease and pathogenesis in systemic lupus erythematosus
Marion, T. N., & Postlethwaite, A. E. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-014-0440-x · Cited by 73
Genetics of the type I interferon pathway in systemic lupus erythematosus
Ghodke‐Puranik, Y., & Niewold, T. B. (2013) · International Journal of Clinical Rheumatology · doi:10.2217/ijr.13.58 · Cited by 77
TANK-Binding Kinase 1-Dependent Responses in Health and Autoimmunity
Louis, C., Burns, C., & Wicks, I. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00434 · Cited by 65
“Given the robust correlation between TFH numbers and high-affinity autoantibody levels, manipulation of the differentiation program and plasticity of TFH cells may provide new therapeutic options in autoimmune diseases, such as SLE and RA.”
BackgroundInfluentialType I interferon–related kidney disorders
Lodi, L., Mastrolia, M. V., Bello, F., Rossi, G. M., Angelotti, M. L., Crow, Y. J., Romagnani, P., & Vaglio, A. (2022) · Kidney International · doi:10.1016/j.kint.2022.02.031 · Cited by 71
Ramantani, G., Häusler, M., Niggemann, P., et al. (2011) · Journal of Child Neurology · doi:10.1177/0883073811408310 · Cited by 63
Self-citationType I interferon dysregulation and neurological disease
McGlasson, S. L., Jury, A., Jackson, A. P., & Hunt, D. P. J. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.143 · Cited by 62
MicroRNA regulation of endothelial TREX1 reprograms the tumour microenvironment
Wilson, R., Espinosa‐Díez, C., Kanner, N., Chatterjee, N., Ruhl, R. A., Hipfinger, C., Advani, S. J., Li, J., Khan, O. F., Franovic, A., et al. (2016) · Nature Communications · doi:10.1038/ncomms13597 · Cited by 67
Whole exome sequencing in childhood-onset lupus frequently detects single gene etiologies
Tirosh, I., Spielman, S., Barel, O., Ram, R., Stauber, T., Paret, G., Rubinsthein, M., Pessach, I. M., Gerstein, M., Anikster, Y., et al. (2019) · Pediatric Rheumatology · doi:10.1186/s12969-019-0349-y · Cited by 66
Lindahl, T. L., Barnes, D. E., Yang, Y., & Robins, P. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370535 · Cited by 74
Systemic lupus erythematosus as a genetic disease
Harley, I. T. W., & Sawalha, A. H. (2022) · Clinical Immunology · doi:10.1016/j.clim.2022.108953 · Cited by 74
TREX1 gene variant in neuropsychiatric systemic lupus erythematosus
de Vries, B., Steup‐Beekman, G. M., Haan, J., Bollen, E. L. E. M., Luyendijk, J. M., Frants, R. R., Terwindt, G. M., van Buchem, M. A., Huizinga, T. W. J., van den Maagdenberg, A. M. J. M., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.114157 · Cited by 64
“gene, encoding the major mammalian 3′-5′ DNA exonuclease, were identified in nine out of 417 SLE patients.”
BackgroundGain-of-function human UNC93B1 variants cause systemic lupus erythematosus and chilblain lupus
David, C., Arango-Franco, C. A., Badonyi, M., Fouchet, J., Rice, G., Didry‐Barca, B., Maisonneuve, L., Seabra, L., Kechiche, R., Masson, C., et al. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20232066 · Cited by 69
DiFrancesco, J. C., Novara, F., Zuffardi, O., Forlino, A., Gioia, R., Cossu, F., Bolognesi, M., Andreoni, S., Saracchi, E., Frigeni, B., et al. (2014) · Neurological Sciences · doi:10.1007/s10072-014-1944-9 · Cited by 58
Innate Immune Signaling by, and Genetic Adjuvants for DNA Vaccination
Kobiyama, K., Jounai, N., Aoshi, T., Tozuka, M., Takeshita, F., Coban, C., & Ishii, K. J. (2013) · Vaccines · doi:10.3390/vaccines1030278 · Cited by 60
“and DNase III in humans were also shown to cause several autoimmune disorders, such as systemic lupus erythematosis [33,35], Aicardi-Goutieres syndrome [36], familial chilblain lupus [37], or retinal vasculopathy with cerebral leukodystrophy [38].”
BackgroundWang, Y., Chen, S., Chen, S., Du, J., Lin, J., Qin, H., Wang, J., Liang, J. F., & Xu, J. (2018) · Arthritis Research & Therapy · doi:10.1186/s13075-018-1640-x · Cited by 59
Neuropathology and Genetics of Cerebroretinal Vasculopathies
Kolar, G. R., Kothari, P. H., Khanlou, N., Jen, J. C., Schmidt, R. E., & Vinters, H. V. (2014) · Brain Pathology · doi:10.1111/bpa.12178 · Cited by 59
“Mutations in TREX1 are implicated in several diseases besides CRV, including Aicardi-Goutieres syndrome (3), familial chilblain lupus (10, 21) and a small percentage of systemic lupus erythematosus patients (11, 15).”
BackgroundSelf-citationPost-Translational Modifications of cGAS-STING: A Critical Switch for Immune Regulation
Yu, Y., Liu, J., Liu, C., Liu, R., Liu, L., Yu, Z., Zhuang, J., & Sun, C. (2022) · Cells · doi:10.3390/cells11193043 · Cited by 61
“Unfortunately, loss-of-function mutations in DNA exonuclease three-prime repair exonuclease 1 (TREX1) interfere with DNA degradation in apoptotic cells and lead to excessive type I IFN signatures that ultimately develop into SLE or AGS [194,195].”
BackgroundPathogenesis of cutaneous lupus erythematosus: common and different features in distinct subsets
Wenzel, J., Zahn, S., & Tüting, T. (2010) · Lupus · doi:10.1177/0961203310370046 · Cited by 63
Aicardi–Goutieres syndrome, a rare neurological disease in children: A new autoimmune disorder?
Fazzi, E. M., Cattalini, M., Orcesi, S., Tincani, A., Andréoli, L., Balottin, U., Simone, M. D., Fredi, M., Facchetti, F., Galli, J., et al. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.08.012 · Cited by 61
Neurological Disease in Lupus: Toward a Personalized Medicine Approach
McGlasson, S. L., Wiseman, S. J., Wardlaw, J. M., Dhaun, N., & Hunt, D. P. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01146 · Cited by 63
Role of DNA/RNA sensors and contribution to autoimmunity
Smith, S., & Jefferies, C. A. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.07.019 · Cited by 61
Günther, C., Meurer, M., Stein, A., Viehweg, A., & Lee‐Kirsch, M. A. (2009) · Dermatology · doi:10.1159/000222430 · Cited by 58
Self-citationFunction of Protein S-Palmitoylation in Immunity and Immune-Related Diseases
Zhang, Y., Qin, Z., Sun, W., Chu, F., & Zhou, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.661202 · Cited by 74
King, C. R., Liu, Y., Amato, K. A., Schaack, G. A., Mickelson, C. K., Sanders, A. E., Hu, T., Gupta, S., Langlois, R. A., Smith, J. A., et al. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.08.001 · Cited by 57
Autoimmunity and Primary Immunodeficiency Disorders
Allenspach, E. J., & Torgerson, T. R. (2016) · Journal of Clinical Immunology · doi:10.1007/s10875-016-0294-1 · Cited by 57
Miyazaki, T., Kim, Y.-S., Yoon, J., Wang, H., Suzuki, T., & Morse, H. C. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.547331 · Cited by 63
“4 The abbreviations used are: SLE, systemic lupus erythematosus; AGS, Aicardi-Goutières syndrome; BER, base excision repair; IFN1, type I interferon; PARP1, poly(ADP-ribose) polymerase-1; RVCL, retinal vasculopathy with cerebral leukodystrophy; TREX1, 3 repair exonuclease 1; ZF, zinc finger; ssDNA, single-stranded DNA…”
BackgroundInfluentialStructural basis of human TREX1 DNA degradation and autoimmune disease
Zhou, W., Richmond-Buccola, D., Wang, Q., & Kranzusch, P. J. (2022) · Nature Communications · doi:10.1038/s41467-022-32055-z · Cited by 58
Genetics of SLE: Functional Relevance for Monocytes/Macrophages in Disease
Byrne, J. C., Gabhann, J. N., Lazzari, E., Mahony, R., Smith, S., Stacey, K., Wynne, C., & Jefferies, C. A. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/582352 · Cited by 57
“Various genetic studies have identified a number of loss-offunction mutations in TREX1 that give rise to SLE, familial chilblain lupus (FCL), or Aicardi-Gautieres syndrome (AGS), an autoimmune disorder that presents as early onset encephalopathy resulting in severe intellectual and physical handicap [119–122].”
BackgroundGenetics and molecular biology of brain calcification
Deng, H., Zheng, W. L., & Jankovic, J. J. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.04.004 · Cited by 57
Aicardi–Goutières syndrome harbours abundant systemic and brain-reactive autoantibodies
Cuadrado, E., Vanderver, A. L., Brown, K. J., Sandza, A., Takanohashi, A., Jansen, M. H., Anink, J. J., Herron, B. M., Orcesi, S., Olivieri, I., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-205396 · Cited by 55
The Exonuclease Trex1 Restrains Macrophage Proinflammatory Activation
Pereira-Lopes, S., Celhar, T., Sans-Fons, G., Serra, M., Fairhurst, A.-M., Lloberas, J., & Celada, A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301603 · Cited by 53
Type I interferonopathies—an expanding disease spectrum of immunodysregulation
Lee‐Kirsch, M. A., Wolf, C., Kretschmer, S., & Roers, A. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0500-x · Cited by 60
Self-citationTREX1 – Apex predator of cytosolic DNA metabolism
Simpson, S. R., Hemphill, W. O., Hudson, T., & Perrino, F. W. (2020) · DNA repair · doi:10.1016/j.dnarep.2020.102894 · Cited by 58
Self-citationIntracellular DNA sensors in immunity
Takeshita, F., & Ishii, K. J. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.05.009 · Cited by 53
An emerging role for calcium signalling in innate and autoimmunity via the cGAS-STING axis
Mathavarajah, S., Salsman, J., & Dellaire, G. (2019) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2019.04.003 · Cited by 59
Systemic lupus erythematosus genetics: insights into pathogenesis and implications for therapy
Ghodke‐Puranik, Y., Olferiev, M., & Crow, M. K. (2024) · Nature Reviews Rheumatology · doi:10.1038/s41584-024-01152-2 · Cited by 72
“Rare variants in type I interferon pathway genes, including TREX1 (encoding a DNase), OASL (encoding an anti-viral enzyme) and IFIH1 (encoding the RNA sensor MDA5), have been identified in patients with SLE 48–50 .”
Perl, A. (2009) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32832efe6b · Cited by 54
Aspects of innate immunity in Sjögren's syndrome
Low, H. Z., & Witte, T. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3318 · Cited by 53
“Most of the cases we contributed to the latter analysis were patients who had suff ered from SLE and secondary SS, and subsequent careful exami na tion of relatives of these index subjects revealed that several family members carrying the TREX-1 mutations also suff ered from primary SS (unpub lished observa tions).”
BackgroundInfluentialSelf-citationFamilial Chilblain Lupus - What Can We Learn from Type I Interferonopathies?
Fiehn, C. (2017) · Current Rheumatology Reports · doi:10.1007/s11926-017-0689-x · Cited by 53
Self-DNA at the Epicenter of SLE: Immunogenic Forms, Regulation, and Effects
Soni, C., & Reizis, B. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01601 · Cited by 58
“Even though AGS and SLE share several overlapping disease manifestations, ss/dsDNA specific antibodies were not detected in any of the AGS patient sera in this study (123).”
BackgroundGenetics of systemic lupus erythematosus and Sjögren's syndrome: an update
Teruel, M., & Alarcón-Riquelme, M. E. (2016) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000310 · Cited by 54
Recent developments in systemic lupus erythematosus pathogenesis and applications for therapy
Lo, M. S., & Tsokos, G. C. (2017) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000474 · Cited by 53
Systemic Lupus Erythematosus and DNA Degradation and Elimination Defects
Arneth, B. M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01697 · Cited by 56
Santa, P., Garreau, A., Serpas, L., Ferrière, A., Blanco, P., Soni, C., & Sisirak, V. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.629922 · Cited by 71
“AGS is an inflammatory syndrome characterized by an encephalitis accompanied by lymphocyte infiltration in the central nervous system and an IFN-I signature (124).”
BackgroundDeregulated Type I IFN Response in TREX1-Associated Familial Chilblain Lupus
Peschke, K., Friebe, F., Zimmermann, N., Wahlicht, T., Schumann, T., Achleitner, M., Berndt, N., Luksch, H., Behrendt, R., Lee‐Kirsch, M. A., et al. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.496 · Cited by 53
Self-citationZhong, H., Li, X.-L., Li, M., Hao, L.-X., Chen, R.-W., Xiang, K., Qi, X., Ma, R. Z., & Su, B. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3514 · Cited by 53
“As for the SNPs in FCGR2A and TREX1, although no significant association was detected (probably due to the small sample size), the same trend was observed as reported in previous studies [14,18,37].”
BackgroundResultA de novo p.Asp18Asn mutation in TREX1 in a patient with Aicardi–Goutières syndrome
Haaxma, C. A., Crow, Y. J., Steensel, M. A. M. V., Lammens, M. M. Y., Rice, G., Verbeek, M. M., & Willemsen, M. A. A. P. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33620 · Cited by 49
“Additionally, this changewas absent in 1,712 control samples sequenced in another study [Lee-Kirsch et al., 2007b].”
BackgroundTüngler, V., Silver, R. M., Walkenhorst, H., Günther, C., & Lee‐Kirsch, M. A. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.10813.x · Cited by 50
Self-citationAicardi–Goutieres syndrome: from patients to genes and beyond
Chahwan, C., & Chahwan, R. (2011) · Clinical Genetics · doi:10.1111/j.1399-0004.2011.01825.x · Cited by 53
Budarf, M. L., Goyette, P., Boucher, G., Lian, J., Graham, R., Claudio, J. O., Hudson, T. J., Gladman, D. D., Clarke, A. E., Pope, J. E., et al. (2010) · Genes and Immunity · doi:10.1038/gene.2010.47 · Cited by 53
Feng, X., Huang, J., Liu, Y., Xiao, L., Wang, D., Hua, B., Tsao, B. P., & Sun, L. (2014) · Clinical Rheumatology · doi:10.1007/s10067-014-2799-4 · Cited by 46
“To further confirm a link between type I IFN system and genetic defects in SLE, recent studies have identified many lupus-associated genetic variants in genes encoding transcription factors and various molecular components involved in the IFN pathway, such as IRF5, IRF7, IRAK1, TREX1, STAT4, and PTPN22 [26–33].”
BackgroundOrebaugh, C. D., Fye, J. M., Harvey, S. E., Hollis, T., & Perrino, F. W. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.297903 · Cited by 54
Self-citationHuman DNA Exonuclease TREX1 Is Also an Exoribonuclease That Acts on Single-stranded RNA
Yuan, F., Dutta, T., Wang, L., Song, L., Gu, L., Qian, L., Benitez, A., Ning, S., Malhotra, A., Deutscher, M. P., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.653915 · Cited by 44
The TREX1 C-terminal Region Controls Cellular Localization through Ubiquitination
Orebaugh, C. D., Fye, J. M., Harvey, S. E., Hollis, T., Wilkinson, J. C., & Perrino, F. W. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.503391 · Cited by 53
“The TREX1 CTR is necessary to localize the enzyme to the perinuclear region of the cytosolic compartment (16, 19).”
BackgroundMethodInfluentialSelf-citationGenomics of Systemic Lupus Erythematosus
Hiraki, L. T., & Silverman, E. D. (2017) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2017.04.005 · Cited by 51
Roelofs, M. F., Abdollahi‐Roodsaz, S., Joosten, L. A. B., van den Berg, W. B., & Radstake, T. R. D. J. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23217 · Cited by 51
Goldbach‐Mansky, R. T., Alehashemi, S., & de Jesus, A. A. (2024) · Nature Reviews Rheumatology · doi:10.1038/s41584-024-01184-8 · Cited by 54
“106) and several (mostly heterozygous missense ) variants in RNASE2HA , RNASE2HB and RNASE2HC 107 are enriched in polygenic, non-syndromic SLE cohorts, with a relative risk of 25.3 for patients with SLE carrying a heterozygous TREX1 variant 106 .”
InfluentialVariations of the perforin gene in patients with multiple sclerosis
Cappellano, G., Orilieri, E., Comi, C., Chiocchetti, A., Bocca, S., Boggio, E. M., Bernardone, I. S., Cometa, A. M., Clementi, R., Barizzone, N., et al. (2008) · Genes and Immunity · doi:10.1038/gene.2008.35 · Cited by 45
Pernicious anemia – Genetic insights
Banka, S., Ryan, K. E., Thomson, W., & Newman, W. G. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.01.009 · Cited by 43
Genetic associations in type I interferon related pathways with autoimmunity
Delgado-Vega, A. M., Alarcón-Riquelme, M. E., & Kozyrev, S. V. (2010) · Arthritis Research & Therapy · doi:10.1186/ar2883 · Cited by 50
“31 TREX1 R114H, 158V, P212fs, G227S, SLE, pSS R114H associated with decreased exonuclease [180,181] (DNASEIII) R240S, A247, P272fs, P290L, activity.”
BackgroundInfluentialInborn Errors of Immunity and Autoimmune Disease
Gray, P. E., & David, C. (2023) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2023.04.018 · Cited by 51
Genes Associated with SLE Are Targets of Recent Positive Selection
Ramos, P. S., Shaftman, S. R., Ward, R. C., & Langefeld, C. D. (2014) · Autoimmune Diseases · doi:10.1155/2014/203435 · Cited by 49
Interferon regulatory factors: critical mediators of human lupus
Jensen, M. A., & Niewold, T. B. (2014) · Translational research · doi:10.1016/j.trsl.2014.10.002 · Cited by 42
The emerging roles of the STING adaptor protein in immunity and diseases
Liu, X., & Wang, C. (2015) · Immunology · doi:10.1111/imm.12561 · Cited by 43
Does type-I interferon drive systemic autoimmunity?
Picard, C., & Bélot, A. (2017) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.07.001 · Cited by 43
Microbial and genetic-based framework identifies drug targets in inflammatory bowel disease
Wang, Z., Guo, K., Gao, P., Pu, Q., Lin, P., Qin, S., Xie, N., Hur, J., Li, C. L., Huang, C., et al. (2021) · Theranostics · doi:10.7150/thno.59196 · Cited by 43
“Recent research has implicated that STING agonists might have a potential therapeutic benefit in anticancer immune therapy [61] and antiviral responses [62], and STING inhibition may be promising for treating inflammatory diseases (such as AGS) through genetic approaches [63] or chemical inhibitors [64].”
BackgroundThe Autoimmune Tautology: From Polyautoimmunity and Familial Autoimmunity to the Autoimmune Genes
Anaya, J., Rojas‐Villarraga, A., & García‐Carrasco, M. (2012) · Autoimmune Diseases · doi:10.1155/2012/297193 · Cited by 50
Endogenous retroelements and autoimmune disease
Stetson, D. B. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.09.007 · Cited by 44
STING Contributes to Abnormal Bone Formation Induced by Deficiency of DNase II in Mice
Baum, R., Sharma, S., Organ, J. M., Jakobs, C., Hornung, V., Burr, D. B., Marshak‐Rothstein, A., Fitzgerald, K. A., & Gravallese, E. M. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39863 · Cited by 40
DNA repair and systemic lupus erythematosus
Meas, R., Burak, M. J., & Sweasy, J. B. (2017) · DNA repair · doi:10.1016/j.dnarep.2017.06.020 · Cited by 42
Lack of Trex1 Causes Systemic Autoimmunity despite the Presence of Antiretroviral Drugs
Achleitner, M., Kleefisch, M., Hennig, A., Peschke, K., Polikarpova, A., Oertel, R., Gabriel, B., Schulze, L., Lindeman, D., Gerbaulet, A., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700714 · Cited by 49
Self-citationEarly onset of autoimmune disease by the retroviral integrase inhibitor raltegravir
Beck-Engeser, G. B., Eilat, D., Harrer, T., Jäck, H.-M., & Wabl, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908074106 · Cited by 40
“That these elements may contribute to autoimmune disease is indicated by the fact that human patients with a deficiency in Trex1, an enzyme that degrades retroelement cDNA (1), may suffer from chilblain lupus (2, 3), systemic lupus erythematosus (4), or Aicardi-Goutières syndrome (2, 3, 5).”
BackgroundImmunogenetics of systemic sclerosis
Dieudé, P., Boileau, C., & Allanore, Y. (2010) · Autoimmunity Reviews · doi:10.1016/j.autrev.2010.09.017 · Cited by 49
DNase-active TREX1 frame-shift mutants induce serologic autoimmunity in mice
Sakai, T., Miyazaki, T., Shin, D.-M., Kim, Y., Qi, C., Fariss, R. N., Munasinghe, J., Wang, H., Kovalchuk, A. L., Kothari, P. H., et al. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.03.001 · Cited by 43
“However, not all C-terminal truncations are associated with RVCL with some being found in individuals diagnosed with SLE [1].”
BackgroundInfluentialSelf-citationMireles-Canales, M. P., González‐Chávez, S. A., Quiñonez-Flores, C. M., León-López, E. A., & Pacheco‐Tena, C. (2018) · Journal of Immunology Research · doi:10.1155/2018/8214379 · Cited by 42
Development of small molecule inhibitors/agonists targeting STING for disease
Liu, K., Lan, Y., Li, X., Li, M., Cui, L., Luo, H., & Luo, L. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110945 · Cited by 42
Chilblains as a Diagnostic Sign of Aicardi-Goutières Syndrome
Abdel‐Salam, G. M. H., El‐Kamah, G. Y., Rice, G., El‐Darouti, M., Gornall, H., Szynkiewicz, M., AYMARD, F., Zaki, M. S., Aleem, A. K. A., Lebon, P., et al. (2010) · Neuropediatrics · doi:10.1055/s-0030-1255059 · Cited by 39
Nucleic acid‐mediated inflammatory diseases
Rigby, R. E., Leitch, A., & Jackson, A. P. (2008) · BioEssays · doi:10.1002/bies.20808 · Cited by 38
Multiple sclerosis–like lesions and type I interferon signature in a patient with RVCL
Schuh, E., Ertl-Wagner, B. B., Lohse, P., et al. (2014) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000055 · Cited by 38
Self-citationGirschick, H. J., Wolf, C., Morbach, H., et al. (2015) · Pediatric Rheumatology · doi:10.1186/s12969-015-0035-7 · Cited by 38
“In addition, signs of autoimmune disease resembling systemic lupus erythematosus (SLE) are commonly observed [2].”
BackgroundSelf-citationTwo further cases of spondyloenchondrodysplasia (SPENCD) with immune dysregulation
Navarro, V., Scott, C., Briggs, T. A., Barète, S., Francès, C., Lebon, P., Maisonobe, T., Rice, G., Wouters, C. H., & Crow, Y. J. (2008) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32518 · Cited by 38
“…and Goutières, 2000; Dale et al., 2000; De Laet et al., 2005; Rasmussen et al., 2005], and the recent identification of TREX1/AGS1 mutations in SLE [Lee-Kirsch et al., 2007] and familial chilblain lupus [Rice et al., 2007b], we are intrigued by the observation of a raised level of…”
BackgroundInfluentialKumar, S., Morrison, J. H., Dingli, D., & Poeschla, E. M. (2018) · Journal of Virology · doi:10.1128/jvi.00001-18 · Cited by 42
“For example, while most AGS-associated TREX1 mutations are autosomal recessive and result in loss of exonuclease activity, most SLE-associated mutant TREX1 proteins are autosomal dominant and do not affect DNase activity (17, 18).”
BackgroundKind, B., Muster, B., Staroske, W., Herce, H. D., Sachse, R., Rapp, A., Schmidt, F., Koss, S., Cardoso, M. C., & Lee-Kirsch, M. A. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu319 · Cited by 38
Self-citationAbe, J., Nakamura, K., Nishikomori, R., Kato, M., Mitsuiki, N., Izawa, K., Awaya, T., Kawai, T., Yasumi, T., Toyoshima, I., et al. (2013) · Rheumatology · doi:10.1093/rheumatology/ket372 · Cited by 43
Metadata
- Authors
- Lee-Kirsch, M. A., Gong, M., Chowdhury, D., Senenko, L., Engel, K., Lee, Y.-A., de Silva, U., Bailey, S. L., Witte, T., Vyse, T. J., Kere, J., Pfeiffer, C., Harvey, S., Wong, A., Koskenmies, S., Hummel, O., Rohde, K., Schmidt, R. E., Dominiczak, A. F., Gahr, M., Hollis, T., Perrino, F. W., Lieberman, J., & Hübner, N.
- Affiliations
- Max Delbrück Center (DE)
- Harvard University (US)
- Technische Universität Dresden (DE)
- Wake Forest University Health Sciences (US)
- Medizinische Hochschule Hannover (DE)
- Hammersmith Hospital (GB)
- Karolinska Institutet (SE)
- Klinik und Poliklinik für Dermatologie (DE)
- University of Helsinki (FI)
- University of Glasgow (GB)
- Corresponding author
- Lee, Young-Ae
- Hübner, Norbert
- ORCID
- Venue
- Nature Genetics
- Published
- 2007-07-29
- Volume
- 39
- Issue
- 9
- Pages
- 1065-1067
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2043959346
- Semantic Scholar
- 443992a86650d6f5f9c909d94b91ccce78822316
- Cited by
- 730
- References
- 15
- Citations by year
- 2026: 21 · 2025: 31 · 2024: 57 · 2023: 32 · 2022: 30 · 2021: 36 · 2020: 23 · 2019: 44 · 2018: 34 · 2017: 39 · 2016: 48 · 2015: 43 · 2014: 38 · 2013: 57 · 2012: 48
- FWCI
- 25.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM069962, GM 069962)
- National Institute of Allergy and Infectious Diseases (AI45587)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- TREX1, systemic lupus erythematosus, 3'-5' exonuclease, Aicardi-Goutières syndrome, monoallelic variants, frameshift mutation, missense mutations, 3'UTR variant, subcellular targeting, genetic susceptibility
- MeSH terms
- Exodeoxyribonucleases, Gene Frequency, Genotype, HeLa Cells, Humans, Lupus Erythematosus, Cutaneous, Mutation, Phosphoproteins, Endosomes, Recombinant Proteins, Frameshift Mutation, Protein Structure, Tertiary, Genetic Predisposition to Disease, Mutation, Missense, 3' Untranslated Regions, Green Fluorescent Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.